CASPER PHARMA LLC
Big PharmaCASPER PHARMA LLC is a major pharmaceutical company focused on Cardiovascular, Infectious Disease, Gastroenterology. Key products include TIOCYSTIN.
CASPER PHARMA LLC's Key Drugs
CASPER PHARMA LLC's core commercial portfolio centers on TIOCYSTIN, spanning Cardiovascular and Infectious Disease — its most strategically important drugs approved in the last 15 years.
CASPER PHARMA LLC's Recent FDA Approvals
CASPER PHARMA LLC secured 1 new FDA approval for novel drugs (NDA/BLA) in the last two years.
CASPER PHARMA LLC's Therapeutic Areas
CASPER PHARMA LLC's approved drugs and pipeline span 5 therapeutic areas, led by Cardiovascular and Infectious Disease, across 0 biologic and 8 small-molecule drugs. Weighted by commercial stage — approved drugs count most, then late-stage trials.
CASPER PHARMA LLC's Top Competitors
CASPER PHARMA LLC's closest competitors by therapeutic-area and drug-target overlap include Johnson & Johnson, Sanofi, and Bristol-Myers Squibb. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
CASPER PHARMA LLC Pipeline Snapshot
Active clinical trials for CASPER PHARMA LLC across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • TIOCYSTIN leads revenue
- • Drug-level revenue analysis
Trial Catalysts
- • Cardiovascular pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (1)
Discontinued (0)
Company Info
- First Approval
- 1949-05-18
- Latest
- 2026-06-02
- Applications
- 16